Vardenafil hydrochloride
CAS No. 224785-91-5
Vardenafil hydrochloride ( —— )
Catalog No. M21601 CAS No. 224785-91-5
Vardenafil hydrochloride is a New Phosphodiesterase Type 5(PDE5) Inhibitor in the Treatment of Erectile Dysfunction in Men With Diabetes.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
100MG | 61 | Get Quote |
|
200MG | 113 | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameVardenafil hydrochloride
-
NoteResearch use only not for human use.
-
Brief DescriptionVardenafil hydrochloride is a New Phosphodiesterase Type 5(PDE5) Inhibitor in the Treatment of Erectile Dysfunction in Men With Diabetes.
-
DescriptionVardenafil hydrochloride is a New Phosphodiesterase Type 5(PDE5) Inhibitor in the Treatment of Erectile Dysfunction in Men With Diabetes.
-
Synonyms——
-
PathwayAngiogenesis
-
TargetPDE
-
RecptorPDE5
-
Research AreaMetabolic Disease
-
IndicationErectile Dysfunction
Chemical Information
-
CAS Number224785-91-5
-
Formula Weight525.06
-
Molecular FormulaC23H33ClN6O4S
-
Purity>98% (HPLC)
-
SolubilityDMSO:100 mg/mL (190.45 mM; Need ultrasonic); H2O:100 mg/mL (190.45 mM)
-
SMILESCl.CCCc1nc(C)c2n1nc([nH]c2=O)-c1cc(ccc1OCC)S(=O)(=O)N1CCN(CC)CC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Irwin Goldstein Jay M Young Jerome Fischer.Vardenafil a New Phosphodiesterase Type 5 Inhibitor in the Treatment of Erectile Dysfunction in Men With Diabetes: A Multicenter Double-Blind Placebo-Controlled Fixed-Dose Study.Diabetes Care. 2003 Mar;26(3):777-83.
molnova catalog
related products
-
Piclamilast
Piclamilast is a PDE4 inhibitor.
-
Lirimilast
Lirimilast (BAY 19-8004;BAY 198004) is a potent and selective PDE4 inhibitor for the treatment of COPD.
-
N-Methylbenzamide
N-Methylbenzamide is a potent phosphodiesterase 10A (PDE10A) inhibitor,with anti-cancer activity.